Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
N2586 | 1 | MCP-1 (MCAF) | 251.0 | 50 | |||||||
RA1869 | JNK-IN-8 | 3.0 | uM | 1 | MCP-1 (MCAF) | 115.0 | 60 | ||||
RA1869 | PH-797804 | 0.6 | uM | 1 | MCP-1 (MCAF) | 638.0 | 55 | ||||
N2759 | JNK-IN-8 | 3.0 | uM | 1 | MCP-1 (MCAF) | 62.0 | 59 | ||||
N2759 | PH-797804 | 0.6 | uM | 1 | MCP-1 (MCAF) | 195.0 | 55 | ||||
RA1931 | JNK-IN-8 | 3.0 | uM | 1 | MCP-1 (MCAF) | 62.5 | 46 | ||||
RA1931 | PH-797804 | 0.6 | uM | 1 | MCP-1 (MCAF) | 137.0 | 44 | ||||
N2586 | JNK-IN-8 | 3.0 | uM | 1 | MCP-1 (MCAF) | 121.0 | 45 | ||||
N2586 | PH-797804 | 0.6 | uM | 1 | MCP-1 (MCAF) | 194.0 | 47 | ||||
RA1869 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MCP-1 (MCAF) | 81.0 | 52 | ||||
RA1869 | IKK16 | 2.0 | uM | 1 | MCP-1 (MCAF) | 101.0 | 56 | ||||
N2759 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MCP-1 (MCAF) | 102.0 | 46 | ||||
N2759 | IKK16 | 2.0 | uM | 1 | MCP-1 (MCAF) | 60.0 | 57 | ||||
RA1931 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MCP-1 (MCAF) | 159.0 | 55 | ||||
RA1931 | IKK16 | 2.0 | uM | 1 | MCP-1 (MCAF) | 104.0 | 50 | ||||
N2586 | 5z-7-oxozeaenol | 0.6 | uM | 1 | MCP-1 (MCAF) | 107.5 | 46 | ||||
N2586 | IKK16 | 2.0 | uM | 1 | MCP-1 (MCAF) | 127.0 | 52 | ||||
RA1869 | Tofacitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 322.0 | 53 | ||||
RA1869 | 1 | MCP-1 (MCAF) | 415.0 | 53 | |||||||
N2759 | Tofacitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 240.0 | 57 | ||||
N2759 | 1 | MCP-1 (MCAF) | 170.5 | 54 | |||||||
RA1931 | Tofacitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 157.0 | 47 | ||||
RA1931 | 1 | MCP-1 (MCAF) | 183.0 | 77 | |||||||
N2586 | Tofacitinib | 0.3 | uM | 1 | MCP-1 (MCAF) | 266.0 | 55 | ||||
N2586 | 1 | MCP-1 (MCAF) | 219.0 | 43 |